GORD and GLP-1 receptor agonists: an emerging concern for gastroenterologists
It can help you bounce back from injuries in as little as 3-10 days
They help define the magnitude of GcgR agonism that can be tolerated in the context of GLP-1R agonism, as well as the degree of additional efficacy that it might yet be possible to achieve
Then as we set our new years resolutions for 2025, there came an urgent warning from the UKs Medicines and Healthcare products Regulatory Agency (MHRA)
Semaglutide, while transformative in its ability to regulate blood glucose and promote weight loss, can induce gastrointestinal side effects such as nausea, vomiting, and diarrhea
A recent study published by the American Diabetes Association concluded that semaglutide-based medications like Ozempic and Wegovy may reduce the 10-year risk for type 2 diabetes